AU6512296A - Use of a non-steroidal anti-inflammatory drug for topical and systemic treatment of acute and chronic polypoid rhinosinusitis - Google Patents

Use of a non-steroidal anti-inflammatory drug for topical and systemic treatment of acute and chronic polypoid rhinosinusitis

Info

Publication number
AU6512296A
AU6512296A AU65122/96A AU6512296A AU6512296A AU 6512296 A AU6512296 A AU 6512296A AU 65122/96 A AU65122/96 A AU 65122/96A AU 6512296 A AU6512296 A AU 6512296A AU 6512296 A AU6512296 A AU 6512296A
Authority
AU
Australia
Prior art keywords
topical
chronic
acute
steroidal anti
inflammatory drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65122/96A
Other languages
English (en)
Inventor
Uwe Juergens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU6512296A publication Critical patent/AU6512296A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU65122/96A 1995-07-20 1996-07-18 Use of a non-steroidal anti-inflammatory drug for topical and systemic treatment of acute and chronic polypoid rhinosinusitis Abandoned AU6512296A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19526425 1995-07-20
DE19526425 1995-07-20
PCT/DE1996/001304 WO1997003659A1 (fr) 1995-07-20 1996-07-18 Utilisation d'un medicament anti-inflammatoire non-steroidien pour le traitement topique et general de la rhino-sinusite polypoide aigüe et chronique

Publications (1)

Publication Number Publication Date
AU6512296A true AU6512296A (en) 1997-02-18

Family

ID=7767281

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65122/96A Abandoned AU6512296A (en) 1995-07-20 1996-07-18 Use of a non-steroidal anti-inflammatory drug for topical and systemic treatment of acute and chronic polypoid rhinosinusitis

Country Status (4)

Country Link
EP (1) EP0839031A1 (fr)
AU (1) AU6512296A (fr)
DE (2) DE19680594D2 (fr)
WO (1) WO1997003659A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
US6380222B2 (en) 1996-10-11 2002-04-30 Astrazeneca Ab Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
US7345051B2 (en) 2000-01-31 2008-03-18 Genaera Corporation Mucin synthesis inhibitors
US20020147216A1 (en) * 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors
JP2004507444A (ja) * 2000-01-31 2004-03-11 ジェネーラ　コーポレーション ムチン合成インヒビター
EA033355B1 (ru) * 2015-08-18 2019-10-31 State Institution The Republican Center For Res And Practice In Otorhinolaryngology Rnpc Otorinolari Способ лечения хронического полипозного риносинусита у пациента с аспириновой триадой
DE202015106123U1 (de) * 2015-10-23 2016-10-27 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Monoterpenhaltige Zusammensetzung zur Behandlung von Erkrankungen der Nase
WO2019190503A1 (fr) * 2018-03-28 2019-10-03 Cove Bio Llc Procédés et compositions pour le traitement de la maladie de parkinson

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933365A (en) * 1989-01-25 1990-06-12 American Home Products Corporation Phospholipase A2 inhibitors
ES2106770T3 (es) * 1990-09-05 1997-11-16 Ciba Geigy Ag Compuestos difenilicos como inhibidores del metabolismo del acido araquidonico y su empleo en composiciones farmaceuticas.
AU666852B2 (en) * 1991-05-01 1996-02-29 Henry M. Jackson Foundation For The Advancement Of Military Medicine A method for treating infectious respiratory diseases
DE4333794A1 (de) * 1993-10-04 1995-04-06 Carl Heinrich Dr Weischer Neue Acetyl-Salicylsäure-Derivate zur Bekämpfung von Entzündungs- und Schmerzzuständen sowie zur Thromboseprophylaxe und -terapie

Also Published As

Publication number Publication date
DE19680594D2 (de) 1997-09-18
EP0839031A1 (fr) 1998-05-06
DE29680627U1 (de) 1999-06-02
WO1997003659A1 (fr) 1997-02-06

Similar Documents

Publication Publication Date Title
AU2582799A (en) Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery
AU7484198A (en) Topical spray for burn treatment and anti-infection
DE69421685D1 (de) Entzündunghemmendes und analgetisches transdermales Gel enthaltend Ketoprofen
AU6046396A (en) Tricot-like pouch for the delivery of topical drugs and cosm etics
AU4209400A (en) Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
AU6392496A (en) The combination of topical nasal antihistamines and topical nasal steroids
AU7070596A (en) Transdermal administration of olanzapine
AU4916696A (en) Improved topical application emulsions
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
IS4557A (is) Notkun fumagillóls og afleiða þess við framleiðslu lyfja gegn þarmasýkingu
AU6512296A (en) Use of a non-steroidal anti-inflammatory drug for topical and systemic treatment of acute and chronic polypoid rhinosinusitis
AU4451501A (en) Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitor drugs for use transdermally and a process for the manufacture thereof
DE69524550D1 (de) Entzündungshemmende schmerzstillende anhaftende Zubereitungen
AU3951595A (en) Coating for taste masking orally administered bitter drugs
AU6698996A (en) A film for topical use in the treatment of wounds
DE69328067D1 (de) Entzündungshemmendes und analgetisches Diclofenac-Gel
AU4536796A (en) Dermatological use of vitamin d derivatives
AU2003235743A1 (en) Topical application of alpha-dfmo and anti-inflammatory drug for treatment of actinic keratoses
AU2001290961A1 (en) Method for topical treatment of anthralin-responsive dermatological disorders
AU4170299A (en) Composition for the transdermal administration of non-steroidal anti-inflammatory drugs
AU2187699A (en) Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
AU5986298A (en) Acetylsalicylic acid-containing transdermal therapeutic system with absorption enhancement
AU1727297A (en) Application of pyrrolidine derivatives to the preparation of medicaments intended to the treatment of drug abuse
EP0776666A3 (fr) Médicament analgésique et antiinflammatoire
DE69636254D1 (de) Bismut enthaltende arzneimittel in topischen darreichungsformen